NCT03662685: Immunogenetic Profiling of Goeckerman Therapy in the Treatment of Psoriasis Vulgaris |
|
|
| Active, not recruiting | 4 | 15 | US | Goeckerman Therapy, Combination Treatment with Phototherapy and Crude Coal Tar, Goeckerman Regimen, Crude Coal Tar Only, Coal tar, Phototherapy Only, Ultraviolet B, Narrowband ultraviolet B, NB-UVB, UVB phototherapy, Phototherapy, Light treatment | University of California, San Francisco, National Psoriasis Foundation | Psoriasis Vulgaris, Psoriasis | 05/24 | 05/24 | | |
ADapt, NCT05369403: A Study of Lebrikizumab (LY3650150) in Adult and Adolescent Participants With Moderate-to-Severe Atopic Dermatitis Previously Treated With Dupilumab |
|
|
| Active, not recruiting | 3 | 120 | US | Lebrikizumab, LY3650150, DRM06 | Eli Lilly and Company | Atopic Dermatitis | 01/24 | 02/25 | | |
| Recruiting | N/A | 24 | US | Polysomnography (PSG) | University of California, San Francisco, Novartis Pharmaceuticals, National Psoriasis Foundation | Psoriasis Vulgaris | 05/24 | 05/24 | | |
